This innovative platform offers a modular bacterial system free of antibiotics for enhanced protein production. By engineering cells without essential genes, transposons, and toxins, it ensures high protein yield through metabolic coupling.
The University of Tennessee, Knoxville, presents a groundbreaking solution for protein production without the use of antibiotics. This platform utilizes engineered modular bacterial cells that are free from condition-dependent essential genes, endogenous transposons, and toxins. The system is tightly integrated with a protein production module, ensuring that the cell's metabolic function is linked to the overproduction of targeted proteins. This design not only enhances protein yield but also eliminates the reliance on antibiotics, offering a cleaner, more sustainable approach to protein manufacturing.
Key features:
This technology is currently at TRL 2, with initial design and construction of modular cells underway. Future research will focus on medium formulation and demonstrating strain performance for high protein production.
UT offers a partnership model that reduces risk, accelerates time-to-value, and supports long-term growth strategies for industry—providing an attractive platform for companies seeking to formalize collaboration and establish a long-term presence in the East Tennessee region. By aligning institutional investment with regional and national priorities, UT provides a stable and effective platform for industry collaboration, technology deployment, and sustained economic impact.